高级检索
当前位置: 首页 > 详情页

Titanium dioxide nanoparticles induce endoplasmic reticulum stress-mediated apoptotic cell death in liver cancer cells.

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of General Surgery, Guangdong Second Provincial General Hospital, Guangzhou, China [2]The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China [3]Department of Gastrointestinal Surgery, Meizhou People’s Hospital, Meizhou, China [4]Shunde Hospital of Guangzhou University of Traditional Chinese Medicine, Foshan, China [5]Department of Laboratory Medicine, Guangdong Second Provincial General Hospital, Guangzhou, China
出处:
ISSN:

关键词: Titanium dioxide nanoparticles hepatocellular carcinoma nanotoxicity endoplasmic reticulum stress apoptosis

摘要:
Objective: Titanium oxide (TiO2) acts as a photosensitizer in photodynamic therapy by mediating reactive oxygen species (ROS)-induced endoplasmic reticulum (ER) stress. This study aimed to investigate the effect of TiO2 on ER stress in liver cancer cells. Methods: Normal human liver and human hepatocarcinoma cell lines were incubated with various concentrations of TiO2 nanotubes for 48 hours. Cell growth, apoptosis, cell cycle, and cellular ROS were detected. Expression levels of ER stress sensors (PERK and ATF6) and Bax were evaluated by western blot. The effect of TiO2 on liver cancer growth was also investigated in mice in vivo. Results: TiO2 inhibited cell growth, increased apoptosis and cellular ROS levels, and arrested the cell cycle in G1 stage in liver cancer cells. TiO2 also increased PERK, ATF6, and Bax expression levels in liver cancer cells in dose-dependent manners. TiO2 had no significant effect on cell growth, apoptosis, ROS level, cell cycle distribution, or PERK, ATF6, or Bax expression in normal liver cells. TiO2 administration reduced tumor volume and increased PERK, Bax, and ATF6 expression levels in tumor tissues in vivo. Conclusions: TiO2 nanoparticles increased ROS-induced ER stress and activated the PERK/ ATF6/Bax axis in liver cancer cells in vitro and in vivo

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
第一作者:
第一作者机构: [1]Department of General Surgery, Guangdong Second Provincial General Hospital, Guangzhou, China [2]The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China [3]Department of Gastrointestinal Surgery, Meizhou People’s Hospital, Meizhou, China
通讯作者:
通讯机构: [1]Department of General Surgery, Guangdong Second Provincial General Hospital, Guangzhou, China [2]The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China [*1]Department of General Surgery, Guangdong Second Provincial General Hospital, The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510317, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号